Metropolitan Life Insurance CO Abiomed Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

55 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jun 14, 2023	BUY	$242.49 - $301.46 $643,325 - $799,773	2,653 New	2,653 $652 Million
Q3 2022 Mar 30, 2023	SELL	$242.49 - $301.46 $9,457 - $11,756	-39 Reduced 1.45%	2,653 $651,000
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $9,457 - $11,756	-39 Reduced 1.45%	2,653 $652,000
Q2 2022 Jun 20, 2023	BUY	$224.73 - $338.64 $604,973 - $911,618	2,692 New	2,692 $666,000
Q2 2022 Mar 30, 2023	SELL	$224.73 - $338.64 $14,382 - $21,672	-64 Reduced 2.32%	2,692 $666,000
Q2 2022 Aug 11, 2022	SELL	$224.73 - $338.64 $14,382 - $21,672	-64 Reduced 2.32%	2,692 $666,000
Q1 2022 Jun 20, 2023	BUY	$277.25 - $366.29 $764,101 - $1.01 Million	2,756 New	2,756 $912,000
Q1 2022 Mar 30, 2023	SELL	$277.25 - $366.29 $1.23 Million - $1.62 Million	-4,433 Reduced 61.66%	2,756 $912,000
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $1.23 Million - $1.62 Million	-4,433 Reduced 61.66%	2,756 $913,000
Q4 2021 Jun 21, 2023	BUY	$300.63 - $371.35 $2.16 Million - $2.67 Million	7,189 New	7,189 $2.58 Million
Q4 2021 Mar 30, 2023	SELL	$300.63 - $371.35 $35,774 - $44,190	-119 Reduced 1.63%	7,189 $2.58 Million
Q4 2021 Feb 15, 2022	SELL	$300.63 - $371.35 $35,774 - $44,190	-119 Reduced 1.63%	7,189 $2.58 Million
Q3 2021 Jun 21, 2023	BUY	$310.19 - $376.2 $2.27 Million - $2.75 Million	7,308 New	7,308 $2.38 Million
Q3 2021 Mar 30, 2023	SELL	$310.19 - $376.2 $77,547 - $94,050	-250 Reduced 3.31%	7,308 $2.38 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $77,547 - $94,050	-250 Reduced 3.31%	7,308 $2.38 Million
Q2 2021 Jun 21, 2023	BUY	$262.71 - $351.17 $1.98 Million - $2.65 Million	7,542 New	7,542 $2.35 Million
Q2 2021 Mar 30, 2023	SELL	$262.71 - $351.17 $57,533 - $76,906	-219 Reduced 2.82%	7,558 $2.36 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $1.98 Million - $2.65 Million	7,550 Added 94375.0%	7,558 $2.36 Million
Q1 2021 Jun 26, 2023	BUY	$285.92 - $355.13 $2.22 Million - $2.76 Million	7,777 New	7,777 $2.48 Billion
Q1 2021 Mar 30, 2023	SELL	$285.92 - $355.13 $128,092 - $159,098	-448 Reduced 5.45%	7,777 $2.48 Million
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $2.35 Million - $2.92 Million	-8,217 Reduced 99.9%	8 $2.48 Million
Q4 2020 Jun 22, 2023	BUY	$251.88 - $324.2 $2.07 Million - $2.67 Million	8,225 New	8,225 $2.67 Million
Q4 2020 Mar 30, 2023	SELL	$251.88 - $324.2 $93,447 - $120,278	-371 Reduced 4.32%	8,225 $2.67 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $93,447 - $120,278	-371 Reduced 4.32%	8,225 $2.67 Million
Q3 2020 Jun 26, 2023	BUY	$255.22 - $317.0 $2.19 Million - $2.72 Million	8,596 New	8,596 $2.38 Million
Q3 2020 Mar 30, 2023	SELL	$255.22 - $317.0 $86,009 - $106,829	-337 Reduced 3.77%	8,596 $2.38 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $86,009 - $106,829	-337 Reduced 3.77%	8,596 $2.38 Million
Q2 2020 Jun 26, 2023	BUY	$141.4 - $257.09 $1.26 Million - $2.3 Million	8,933 New	8,933 $2.16 Million
Q2 2020 Mar 30, 2023	BUY	$141.4 - $257.09 $22,624 - $41,134	160 Added 1.82%	8,933 $2.16 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $22,624 - $41,134	160 Added 1.82%	8,933 $2.16 Million
Q1 2020 Jul 12, 2023	BUY	$130.51 - $196.01 $1.14 Million - $1.72 Million	8,773 New	8,773 $1.27 Million
Q1 2020 Mar 30, 2023	SELL	$130.51 - $196.01 $16,183 - $24,305	-124 Reduced 1.39%	8,773 $1.27 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $16,183 - $24,305	-124 Reduced 1.39%	8,773 $1.27 Million
Q4 2019 Jul 12, 2023	BUY	$159.31 - $223.54 $1.42 Million - $1.99 Million	8,897 New	8,897 $1.52 Million
Q4 2019 Mar 30, 2023	SELL	$159.31 - $223.54 $3,026 - $4,247	-19 Reduced 0.21%	8,897 $1.52 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $3,026 - $4,247	-19 Reduced 0.21%	8,897 $1.52 Million
Q3 2019 Jul 12, 2023	BUY	$175.89 - $279.23 $1.57 Million - $2.49 Million	8,916 New	8,916 $1.59 Million
Q3 2019 Mar 30, 2023	BUY	$175.89 - $279.23 $30,604 - $48,586	174 Added 1.99%	8,916 $1.59 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $30,604 - $48,586	174 Added 1.99%	8,916 $1.59 Million
Q2 2019 Jul 12, 2023	BUY	$250.96 - $284.94 $2.19 Million - $2.49 Million	8,742 New	8,742 $2.28 Million
Q2 2019 Mar 30, 2023	BUY	$250.96 - $284.94 $115,943 - $131,642	462 Added 5.58%	8,742 $2.28 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $115,943 - $131,642	462 Added 5.58%	8,742 $2.28 Million
Q1 2019 Jul 13, 2023	BUY	$276.39 - $362.25 $2.29 Million - $3 Million	8,280 New	8,280 $2.36 Million
Q1 2019 Mar 30, 2023	BUY	$276.39 - $362.25 $2.29 Million - $3 Million	8,280 New	8,280 $2.36 Million
Q1 2019 May 16, 2019	SELL	$276.39 - $362.25 $5.83 Million - $7.64 Million	-21,103 Reduced 71.82%	8,280 $2.36 Million
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $5.74 Million - $7.53 Million	20,784 Added 241.7%	29,383 $1.89 Million
Q4 2018 Jul 13, 2023	BUY	$281.08 - $444.25 $2.42 Million - $3.82 Million	8,599 New	8,599 $2.8 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $5,621 - $8,885	-20 Reduced 0.23%	8,599 $2.8 Million
Q3 2018 Jul 13, 2023	BUY	$354.53 - $449.75 $3.06 Million - $3.88 Million	8,619 New	8,619 $3.88 Billion
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $55,306 - $70,161	156 Added 1.84%	8,619 $3.88 Million
Q2 2018 Aug 15, 2018	SELL	$278.07 - $446.21 $1.54 Million - $2.47 Million	-5,525 Reduced 39.5%	8,463 $0
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $20,018 - $30,768	104 Added 0.75%	13,988 $0
Q4 2017 Feb 15, 2018	SELL	$168.78 - $199.74 $4.62 Million - $5.47 Million	-27,370 Reduced 66.35%	13,884 $2.6 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $161,382 - $187,146	1,110 Added 2.77%	41,254 $6.96 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,144	40,144 $5.75 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account